Skip to content

Ginkgo Bioworks DNA Other income, net (Note 6)

Other income, net (Note 6) at other companies

Azenta logo
AzentaAZTA
$4.06M+251%
Sana Biotechnology logo
Sana BiotechnologySANA
$453K+81.9%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
-$494K-2,158%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Charles River Laboratories logo
Charles River LaboratoriesCRL
TEC
Bio-TechneTECH

Segments

By segment

See full
Reportable Segment-$4.76M-112%

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's other income, net (note 6)?
Ginkgo Bioworks (DNA) reported other income, net (note 6) of -$4.77M in Q1 2026.
How has Ginkgo Bioworks's other income, net (note 6) changed year-over-year?
Ginkgo Bioworks's other income, net (note 6) decreased by 111.8% year-over-year, from -$2.25M to -$4.77M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.